Aina Balto
Contact
Send email {model.translations.sendEmailTo} Aina.Balto@fhi.no
Department
Responsibilities
Data management, cancer epidemiology, statistician for the national quality registry for colorectal cancer
Projects and publications
- Elin Marthinussen Gustavsen, Stig Norderval, Liv Marit Rønning Dørum, Aina Balto, Ragnhild Heimdal, Barthold Gisle Vonen, Eva Stensland, Ellinor Christin Haukland, Beate Kristin Hauglann, (2024). Socioeconomic and geographic variation in adjuvant chemotherapy among elderly patients with stage III colon cancer in Norway – a national register-based cohort study. Research in Health Services and Regions doi: 10.1007/s43999-024-00057-7
- Kathinka Schmidt Slørdahl, Aina Balto, Marianne Guren, Arne Wibe, Hartwig Kørner, Stig Norderval, Ylva Maria Gjelsvik, Tor Åge Myklebust, Inger Kristin Larsen, (2024). Patient-reported outcomes after treatment for rectal cancer - A prospective nationwide study. Colorectal Disease s. 1-13. doi: 10.1111/codi.17231
- Synne-Kristin Hoffart Bøhn, Karianne Svendsen, Aina Balto, Ylva Maria Gjelsvik, Tor Åge Myklebust, Elin Børøsund, Hege Randi Eriksen, Anders Meland, Kjersti Østby, Lise Solberg Nes, Cecilie E. Kiserud, Kristin Valborg Reinertsen, Giske Ursin, (2024). Health-related quality of life among women diagnosed with in situ or invasive breast cancer and age-matched controls: a population-based study. Journal of Patient-Reported Outcomes doi: 10.1186/s41687-024-00781-1
- Karianne Svendsen, Sigrid Leithe, Cassia Bree Trewin-Nybråten, Aina Balto, Lise Solberg Nes, Anders Meland, Elin Børøsund, Cecilie E. Kiserud, Kristin Valborg Reinertsen, Hege R. Eriksen, Ylva Maria Gjelsvik, Giske Ursin, (2024). How Did Breast Cancer Patients Fare during Different Phases of the COVID-19 Pandemic in Norway Compared to Age-Matched Controls?. Cancers doi: 10.3390/cancers16030602
- Manoj Amrutkar, Kjersti Berg, Aina Balto, Miguel Garcia Skilbrei, Anette Vefferstad Finstadsveen, Monica Aasrum, Ivar Prydz Gladhaug, Caroline Sophie Verbeke, (2023). Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis. Cancer Cell International s. 1-17. doi: 10.1186/s12935-023-02852-7